Bartosz U.
- Country
- Poland
- Department
- Odział Radioterapii i Onkologii Ginekologicznej
Research Overview
- Phase 3 Study Comparing Rinatabart Sesutecan Versus Investigator's Choice in Patients With Recurrent or Progressive Endometrial Cancer Following Platinum-Based and PD(L)-1 Therapy
- Sacituzumab Tirumotecan With or Without Bevacizumab Versus Standard of Care in Patients With Newly Diagnosed Advanced HRD-Negative Ovarian Cancer Following Platinum-Based Chemotherapy
- Phase 3 Randomized Study of Rinatabart Sesutecan + Bevacizumab vs Bevacizumab in Recurrent Platinum‑Sensitive Ovarian Cancer after Second‑Line Platinum Doublet
Data & Insights
Has run more than one trial at 114 of 195 partner sites.
Specializations
Oncology Focus
This investigator specializes in treating various types of gynecological cancers and hereditary cancer syndromes, with particular emphasis on BRCA-mutated cancers.
- Ovarian Cancer Management
- Epithelial Ovarian Cancer
- Platinum-Sensitive Disease
The investigator's work encompasses comprehensive treatment approaches for various stages of ovarian cancer, including recurrent cases.
Advanced Cancer Care
The investigator has developed expertise in treating metastatic cancers across multiple organ systems, focusing on targeted therapeutic approaches.
- Metastatic Breast Cancer
- Pancreatic Cancer
- Prostate Cancer
Their practice includes managing complex cases requiring long-term therapeutic interventions.
Precision Medicine
The investigator focuses on genetic-based treatment approaches, particularly in patients with identified genetic mutations.
- BRCA Mutation Analysis
- Endometrial Cancer
- Targeted Therapies
Their work integrates genetic testing with personalized treatment strategies for optimal patient outcomes.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.